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Monitoring Early-Stage Protein Aggregation by an Aggregation-Induced
Emission Fluorogen
Abstract

Highly ordered protein aggregates, termed amyloid fibrils, are associated with a broad range of diseases, many
of which are neurodegenerative, for example, Alzheimer's and Parkinson's. The transition from soluble,
functional protein into insoluble amyloid fibril occurs via a complex process involving the initial generation of
highly dynamic early stage aggregates or prefibrillar species. Amyloid probes, for example, thioflavin T and
Congo red, have been used for decades as the gold standard for detecting amyloid fibrils in solution and tissue
sections. However, these well-established dyes do not detect the presence of prefibrillar species formed during
the early stages of protein aggregation. Prefibillar species have been proposed to play a key role in the
cytotoxicity of amyloid fibrils and the pathogenesis of neurodegenerative diseases. Herein, we report a novel
fluorescent dye (bis(triphenylphosphonium) tetraphenylethene (TPE-TPP)) with aggregation-induced
emission characteristics for monitoring the aggregation process of amyloid fibrils. An increase in TPE-TPP
fluorescence intensity is observed only with ordered protein aggregation, such as amyloid fibril formation, and
not with stable molten globules states or amorphously aggregating species. Importantly, TPE-TPP can detect
the presence of prefibrillar species formed early during fibril formation. TPE-TPP exhibits a distinctive
spectral shift in the presence of prefibrillar species, indicating a unique structural feature of these
intermediates. Using fluorescence polarization, which reflects the mobility of the emitting entity, the specific
oligomeric pathways undertaken by various proteins during fibrillation could be discerned. Furthermore, we
demonstrate the broad applicability of TPE-TPP to monitor amyloid fibril aggregation, including under
diverse conditions such as at acidic pH and elevated temperature, or in the presence of amyloid inhibitors.
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ABSTRACT: Highly ordered protein aggregates, termed amyloid fibrils, are associated with a broad range of diseases, many of
which are neurodegenerative, for example Alzheimer’s and Parkinson’s. The transition from soluble, functional protein into insoluble amyloid fibril occurs via a complex process involving the initial generation of highly dynamic early-stage aggregates or prefibrillar species. Amyloid probes, for example thioflavin T and Congo red, have been used for decades as the gold standard for detecting amyloid fibrils in solution and tissue sections. However, these well-established dyes do not detect the presence of prefibrillar species formed during the early stages of protein aggregation. Prefibillar species have been proposed to play a key role in the
cytotoxicity of amyloid fibrils and the pathogenesis of neurodegenerative diseases. Herein, we report a novel fluorescent dye (TPETPP) with aggregation-induced emission characteristics for monitoring the aggregation process of amyloid fibrils. An increase in
TPE-TPP fluorescence intensity is observed only with ordered protein aggregation, such as amyloid fibril formation, and not with
stable molten globules states or amorphously aggregating species. Importantly, TPE-TPP can detect the presence of prefibrillar
species formed early during fibril formation. TPE-TPP exhibits a distinctive spectral shift in the presence of prefibrillar species,
indicating a unique structural feature of these intermediates. Using fluorescence polarization, which reflects the mobility of the
emitting entity, the specific oligomeric pathways undertaken by various proteins during fibrillation could be discerned. Furthermore, we demonstrate the broad applicability of TPE-TPP to monitor amyloid fibril aggregation, including under diverse conditions
such as at acidic pH and elevated temperature, or in the presence of amyloid inhibitors.

INTRODUCTION

Fluorescence-based techniques have been widely used to study
protein structure due to their ease of application, flexibility
and non-invasive nature 1. In particular, dye-based assays have
significantly enhanced our understanding of the complex conformational transition of soluble ordered/disordered proteins
and peptides into insoluble β-sheet rich species, commonly
known as amyloid fibrils. The aggregation of proteins or peptides into amyloid fibrils is a pathological hallmark of more
than 50 human disorders, including Alzheimer’s, Parkinson’s
and dialysis-related amyloidosis 2,3. In contrast, amyloid fibrils
with essential biological activities, often termed functional
amyloid, have been reported 4. In general, protein and peptide
aggregation is not the direct conversion of soluble monomers
to insoluble fibrils. Instead, multiple processes may be involved including the generation of transient, intermediately
folded or unfolded states and oligomers (commonly known as
prefibrillar species) that act as primary nuclei for further fibril
growth 5. These small oligomeric species are considered to be

the dominant cytotoxic forms of misfolded proteins 6,7. However, in situ and ex situ identification and characterisation of
early-stage aggregates are difficult because they are generally
heterogeneous, are present in minute quantities for a limited
time, and are highly dynamic in nature 8. Congo red and thioflavin T (ThT) are the most commonly used dyes in the study
of protein aggregation associated with diseases. The green
birefringence from Congo red under polarized light and the
enhanced fluorescence of ThT are indicative of the presence of
amyloid fibrils. Assays based on Congo red and ThT, however, are not able to detect the presence of early-stage aggregates
9-13
. More recently, penta-formylthiophene acetic acid, 9(dicyanovinyl)-julolidine, Nile red, BODIPY-oligomer, N-aryl
amino naphthalene sulfonate and its analogue, and tryptophanol have been used for the identification of prefibrillar species
of various fibril-forming peptides and proteins 14-19, but most
of these are specific to particular amyloid proteins. Therefore,
novel probes that have broad applicability to report on the
presence of prefibrillar species are desirable.

Figure 1. Fluorescence response of TPE-TPP to different forms of α-LA. (A) Structure of TPE-TPP (top panel) and ThT (bottom panel). (B) Time-course
turbidity at 350 nm of molten globule (black open circle), apo (red triangle) and holo (blue circle) forms of α-LA. (C) In situ TPE-TPP assay of molten
globule (black open circle), apo (blue circle), holo (red triangle), and amyloid fibril-forming RCM α-LA (black circle). (D) TEM images of the holo form
of α-LA and RCM α-LA fibrils formed in the presence of TPE-TPP. 20 µM of dye was used for all fluorescence assays. For TPE-TPP, the excitation and
emission filters were 380/20 and 460/40 nm, respectively. The conditions for formation of the different α-LA aggregates are summarised in Table S1.

Full insight into the self-assembly of peptides and proteins
and their role in disease requires both the identification and
characterisation of early-stage aggregates and other conformational states adopted by the polypeptide chain along the pathway to the formation of amyloid fibrils. Although some progress has been made in this area, a better understanding of the
nanoscale assembly of amyloid fibrils from normally soluble
proteins is crucial for combating protein aggregation diseases
as well as to exploit their potential benefits 20. Previously one
of us (Y.H.) reported that fluorogens with aggregation-induced
emission (AIE) characteristics, such as BSPOTPE and TPETPP (Figure 1A, top panel) are non-fluorescent in solution but
become highly fluorescent when they bind to amyloid fibrils
of insulin and α-synuclein, respectively 21-23. Furthermore, a
competition experiment between ThT (Figure 1A, bottom panel) and TPE-TPP binding to α-synuclein fibrils indicated that
TPE-TPP binds more efficiently (with a Kd of 4.36 µM) to the
same site(s) as that of ThT (whose Kd is 8.48 µM) 21. As derivatives of tetraphenylethene (TPE), a typical AIE luminogen,
the emission of these dyes is triggered by the restriction of
intramolecular motions (RIM) of the phenyl rotors in their
aggregated form 24. Additionally, in their aggregated state the
highly twisted nature of the molecular structure impedes π-π
interactions, thereby displaying strong fluorescence 23,25. Similarly, RIM of AIE can also be achieved upon binding to larger
macromolecules such as proteins. Increasing viscosity, decreasing temperature and elevated pressure are further expected to influence RIM by slowing the intramolecular rotation and hence leading to stronger TPE-TPP fluorescence
emission 23,26.
In the present study, we applied the aforementioned properties of TPE-TPP to investigate protein assembly and disassembly. We find that, upon interacting with protein molecules,
emission from TPE-TPP can specifically monitor the process
of ordered protein aggregation, such as amyloid fibril formation, even under solution conditions of acidic pH and elevated temperature. Compared to ThT, TPE-TPP is markedly
more sensitive with regards to recognition of aged amyloid
fibrils, and no self-quenching of fibril-associated fluorescence
is observed in the presence of excess dye. In contrast, complete loss of ThT fluorescence was observed during extended
incubation of hen egg white lysozyme (HEWL) and κ-casein

fibrils. TPE-TPP fluorescence increases upon generation of
oligomeric assemblies formed during the early-stage of protein
aggregation, and displays a significant spectral shift upon
binding to prefibrillar species. In addition, using a microplatebased in situ TPE-TPP fluorescence assay, we screened three
different types of potential inhibitors of amyloid fibril formation acting at various stages of aggregation. In comparison
to the routinely used amyloid probe ThT, TPE-TPP shows
broader in vitro applicability to investigate ordered protein
aggregation process.
EXPERIMENTAL SECTION

Materials. TPE-TPP was synthesized as described in the literature 21. All other reagents (proteins, amino acids, chemicals,
solvents, etc.) were purchased from Sigma Life Sciences and
Sigma-Aldrich unless otherwise specified. Recombinant D76N
β2m, αB-crystallin and α-synuclein were expressed and purified as described previously 27,28. The determination of protein
concentration is described in SI.
Amorphous aggregation. The change in light scattering at
350 nm was used to monitor amorphous aggregation of α-LA
and hen egg white lysozyme (HEWL). Assay conditions are
described in detail in Table S1 and Table S2. Assays were conducted in Nunc 96 well polypropylene microplates, sealed
with transparency film, incubated at 37 °C and light scattering
was monitored using a Biotek Synergy 2 microplate reader.
Amyloid fibril formation. The fibrillar aggregation of proteins was monitored in Greiner Bio-One 384-well microplates
(Item No.: 784900, small volume, black, flat bottom and nonbinding) using a Biotek Synergy 2 microplate reader. The conditions for fibril formation are described in detail in Tables S13. Transparent sealing film was used to prevent solvent evaporation. ThT fluorescence emission was measured using a
440/40 nm filter for excitation and a 485/20 nm filter for emission, while for TPE-TPP fluorescence, the 380/20 and 460/40
nm filters were used for excitation and emission, respectively,
under the fibrillation conditions appropriate for each protein.
Dye concentrations were 20 µM and 5 µM for in situ and ex
situ assays, respectively. The TPE-TPP fluorescence assay
potentially may be affected by a high-binding microplate,
therefore all TPE-TPP and ThT fluorescence assays were performed using the aforementioned non-binding microplate.

A. RCM α-LA

B. RCM κ-casein

C. HEWL, pH 2.0

D. αB-crystallin

E. D76N β2m

F. α-synuclein

Figure 2. Comparison of the time-course aggregation profiles of six different amyloid fibril-forming proteins as monitored by ThT and TPE-TPP fluorescence. (A-C) In situ and (D-F) ex situ dye-binding fluorescence (normalized) profile of (A) 100 µM RCM α-LA, (B) 50 µM RCM κ-casein, (C) 35 µM
HEWL at pH 2.0, (D) 10 µM αB-crystallin, (E) 40 µM D76N β2m and (F) 40 µM α-synuclein. TPE-TPP fluorescence intensity data are represented as
solid circles and ThT fluorescence as open circles. 20 µM of dye was used for the in situ and 5 µM for the ex situ assays. For ThT, the excitation and emission filters were 440/40 and 485/20 nm, respectively. For TPE-TPP, the excitation and emission filters were 380/20 and 460/40 nm, respectively. Tables S2
and S3 summarize the amyloid fibril-forming conditions for each protein.

Fluorescence polarization. For FP experiments, amyloid fibrils were prepared according to the conditions outlined in
Tables S1-3 using Greiner Bio-One 384-well microplates
(small volume, black, flat bottom, and non-binding) with
transparent sealing film. TPE-TPP was added to 20 µM prior
to incubation of the protein. FP was recorded in situ with a
CLARIOstar microplate reader (BMG Labtech) using the FP
mode and a FP filter set of 380/20 nm for excitation and
485/20 nm for emission. The background fluorescence of
TPE-TPP in the corresponding buffer solution under the respective protein fibrillation conditions was subtracted, and the
change in FP values was expressed in milli-polarization units
(∆mP).
RESULTS AND DISCUSSION

TPE-TPP specifically monitors ordered protein aggregation. To determine whether TPE-TPP can distinguish between
various types of protein aggregates, we measured the response
of TPE-TPP against different aggregation pathways undertaken by the same protein under various experimental conditions.
We first chose α-lactalbumin (α-LA) as the model protein
because it is a well-characterized protein that can form a molten globule, amorphous aggregates and amyloid fibrils under
the appropriate solution conditions (as described in Table S1)
29
. α-LA forms a characteristic molten globule state at pH 2.0,
and Ca2+-free (apo) and Ca2+-bound (holo) α-LA form amorphous aggregates under reducing conditions. The rapid formation of amorphous aggregates upon reduction of α-LA was
apparent from the change of the turbidity of the protein solution with time, as monitored via light scattering at 350 nm
(Figure 1B). Reduced and carboxymethylated (RCM) α-LA,
on the other hand, forms ordered amyloid fibrils under physiological conditions in the presence of Mg2+ and with agitation
30
. Figure 1C shows that TPE-TPP was weakly fluorescent in
the presence of monomeric α-LA prior to incubation. Moreover, no enhancement of TPE-TPP emission was observed dur-

ing the process of molten globule or amorphous aggregate
formation. Interestingly, a significant rise in TPE-TPP fluorescence (in a sigmoidal manner) occurred during the fibrillar
aggregation of RCM α-LA, implying that TPE-TPP is sensitive and selective to amyloid fibril formation. The formation
of amorphous aggregates by holo α-LA, and fibrils by RCM αLA in the presence of ThT and TPE-TPP was confirmed by
transmission electron microscopy (TEM) with negative staining (Figure 1D).
Similar to α-LA, HEWL can form aggregates of different
morphology as described in Table S2; for example, amyloid
fibrils at pH 2.0 and amorphous aggregates at pH 12.2 31,32.
Consistent with the response to the various forms of α-LA,
TPE-TPP remained weakly fluorescent during the entire process of amorphous aggregation of HEWL, as monitored by
light scattering at 350 nm. By contrast, TPE-TPP exhibited
significant fluorescence enhancement, displaying a typical
sigmoidal profile during the formation of lysozyme amyloid
fibrils at pH 2.0 and 55 °C (Figure S1). Under such extreme
pH and temperature conditions, ThT is unstable 33,34.
Moreover, we observed that ThT fluorescence intensity
underwent major fluctuation even after mature fibrils had
formed (see below). In addition to chemical reduction and the
exposure to extreme pH conditions, heat can also denature
proteins and induce aggregate formation. Both ThT and TPETPP fluorescence remained almost unchanged in the presence
of bovine serum albumin (BSA) before and after heating to 95
°C, pH 7.4, i.e. conditions that induce the formation of disordered amorphous aggregates of this protein (Figure S2).
Observing prefibrillar/oligomeric species during protein
aggregation. As TPE-TPP shows specific binding to amyloid
fibrils over amorphous aggregates, we next investigated its
application to follow the kinetics of protein aggregation, specifically amyloid fibril formation by RCM α-LA (Figure 2).
RCM α-LA was incubated with TPE-TPP and ThT inde-

pendently, and the change in TPE-TPP and ThT fluorescence
was monitored over time. TPE-TPP fluorescence intensity
decreased significantly during the first 30 minutes of incubation and remained constant for the first 5.5 h (Figure 2A). The
fluorescence emission of TPE-TPP then increased dramatically reaching a plateau after 8 h of incubation. The commensurate experiment with ThT showed constant weak fluorescence
for the first 7 h of incubation and then a slow increase such
that it had not reached a plateau even after 12 h of incubation.
Thus, there is a notable difference in the fluorescence profiles
of both dyes in the presence of aggregating RCM α-LA. It
appears that TPE-TPP fluorescence is more sensitive to the
early species formed prior to the formation of fibrillar entities
than those detected by ThT fluorescence.
To examine whether this is a general phenomenon, i.e. that
TPE-TPP can monitor species formed early during protein
fibrillation, we extended our studies to other amyloid fibrilforming proteins. Similar to RCM α-LA, TPE-TPP fluorescence intensity exhibited an initial decrease during the incubation period and then rose at an earlier time point than ThT
during the fibrillation process of RCM κ-casein and HEWL
(Figure 2B,C). In each of the three cases examined, the dyes
were mixed with the proteins before aggregation commenced
(i.e. in situ assay; Figures 2A-C). To rule out the possibility of
the early increase in TPE-TPP fluorescence being due to a
change in the rate of aggregation as a result of the interaction
of AIE molecules, we also conducted studies involving the
addition of the dyes to aliquots collected at different time
points during the aggregation process (i.e. ex situ assay). The
molecular chaperone protein αB-crystallin, D76N β2microglobulin (β2m), a naturally occurring amyloidogenic
variant of β2m (the protein involved in dialysis-related amyloidosis), and the synucleinopathies-associated protein αsynuclein, were used in this work as they all readily form fibrils under the conditions tested 35-37. Consistent with the in
situ assays, TPE-TPP showed fluorescence enhancement with
these proteins at time points earlier than ThT (Figure 2D-F).
Both the in situ and ex situ assay results clearly indicate that
TPE-TPP is capable of detecting early stage/prefibrillar aggregating species which are not observed using ThT.
Spectral shift of TPE-TPP fluorescence with different protein species. The normalized emission spectrum of TPE-TPP
exhibited a significant blue and red shift when it was mixed
with purified prefibrillar and fibrillar α-LA, respectively,
compared to that in the presence of the monomeric species
(Figure 3A). The emission spectrum of TPE-TPP exhibited an
emission maximum at 474 nm when mixed with RCM α-LA
monomers, which shifted to 460 nm with prefibrillar RCM αLA. In contrast, the emission maximum was red-shifted to 484
nm when mixed with purified RCM α-LA fibrils. The earlystage species detected at around 6 h by TPE-TPP (Figure 2A)
A.

B.

Figure 3. Fluorescence emission spectrum of TPE-TPP upon binding to
different forms of α-LA. (A) Normalized TPE-TPP fluorescence emission upon binding to fresh, non-aggregated (black curve), prefibrillar
(green curve) and fibrillar (magenta curve) species of RCM α-LA. (B)
TEM image of RCM α-LA prefibrillar species; scale = 100 nm. The
TPE-TPP fluorescence emission spectrum was measured with excitation
at 350 nm.

Figure 4. Fluorescence change at different dye: fibril stoichiometry, and
upon maturation of fibrils. (A) Change in fluorescence intensity with
increasing dye-to-protein concentration ratio. Protein: 10 µM mature αsynuclein fibrils. The data of dye with mature HEWL fibrils are shown in
Figure S4. TPE-TPP fluorescence shown by solid black circle and line,
and ThT fluorescence is represented by an open black circle and dashed
line (B) Fibril maturation-induced quenching of ThT and TPE-TPP fluorescence. Actual TPE-TPP and ThT fluorescence intensity upon binding
to non-incubated 2-day (hollow bar) and upon ageing (solid black bar)
protein fibrils, as indicated in the figure. The concentration of the proteins
and dyes was each 10 µM.

was separated and purified from other RCM α-LA forms using
native agarose gel electrophoresis and an Ultrafree®-DA centrifugal unit, respectively. The Ultrafree®-DA unit utilises
centrifugal force and a microporous membrane to disperse the
agarose gel matrix, thereby allowing recovery of the protein.
The non-fibrillar spherical morphology of the prefibrillar
RCM α-LA was confirmed by TEM (Figure 3B). A similar
hypsochromic shift of TPE-TPP fluorescence emission maximum to ~465 nm was also observed when it was mixed with
prefibrillar D76N β2m, but no significant change in the emission maximum occurred when mixed with fibrillar D76N β2m
compared to the monomeric form of the protein (Figure S3).
Thus, such spectral shifts in TPE-TPP fluorescence emission
can be used to differentiate between various protein forms.
Absence of self-quenching and fibril maturation-induced
fluorescence quenching. Younan and Viles reported that an
excess of ThT can cause quenching of fluorescence upon binding to amyloid β-peptide fibrils 38. To test whether TPE-TPP
has the same behaviour, the dye-to-protein fibril ratio was
increased, and fluorescence spectra were recorded. The concentration of the pre-formed protein fibrils was fixed at 10 µM
and the concentration of dye (ThT or TPE-TPP) was altered
from 1 to 40-50 µM. Consistent with the above study, ThT
fluorescence decreased once the dye-to-protein concentration
ratio was greater than 1:1 for both HEWL and α-synuclein
fibrils (Figure 4A and S4). In contrast, the TPE-TPP fluorescence intensity increased proportionally with the increase in
the dye-to-protein fibril ratio, reaching a plateau when the
molar ratio reached 2:1 dye: fibrillar protein. No selfquenching of fluorescence occurred even when the dye-toprotein fibril ratio was greater than 4:1 for both fibrillar species.
In addition to the problems associated with self-quenching,
we found that ThT only exhibited appreciable fluorescence
with fibrils of κ-casein, D76N β2m and HEWL that were
freshly prepared. In order to examine whether this is also a
limitation of TPE-TPP, the proteins were incubated under
conditions conducive to fibril formation for 48 h. At the end of
the incubation, ThT and TPE-TPP fluorescence spectra of an
aliquot from each protein was measured (before maturation),
and the remainder of the sample was then incubated at room
temperature for an additional 7-30 days and measured (after
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therapeutic
agents that can act on various stages of the amyloid fibril-forming pathway is a challenging task because of
the limitations of routinely used amyloid probes. Since TPETPP can follow the kinetics and reveal the early-stage processes during protein fibrillation, the effect of small molecules
on amyloid fibril formation was investigated. We examined
the effects of lysine and arginine, well-described potent inhibitors of protein aggregation 40-42, on RCM α-LA fibrillation
using TPE-TPP and ThT fluorescence assays (Figure 5A,B).
No significant increase in TPE-TPP fluorescence was observed when RCM α-LA was incubated in the presence of
lysine or arginine, suggesting complete suppression of the
fibrillation process (Figure 5A). The inhibitory effect of lysine
and arginine was confirmed using a ThT-based fluorescence
assay (Figure 5B).
Quinacrine, a tricyclic acridine compound, has also been
extensively studied for its potential treatment of prion diseases
and has been reported to inhibit amyloid β peptide fibrillation
43-45
. We investigated the effect of quinacrine on RCM α-LA
amyloid fibril formation via TPE-TPP fluorescence (Figure
5C). Whilst quinacrine did not completely inhibit fibril formation by RCM α-LA, it slowed its rate of fibril formation

and resulted in a change in fibril morphology, as evident by
TEM (Figure S5A). When incubated in the presence of quinacrine, RCM α-LA amyloid fibrils (cf Figure 1D) were much
shorter with more globular and spherical aggregates when
quinacrine was not present (Figure S5A). In addition, Ponceau
S, a diazo dye that is regularly used as a reversible stain for the
detection of proteins in Western blotting 46, modulates RCM
α-LA fibril formation (Figure 5D). When monitored by TPETPP fluorescence, fibril formation by RCM α-LA in the presence of Ponceau S had an extended lag phase by about 1.5 h
compared to when Ponceau S was not present. By prolonging
the lag phase, the diazo dye acts on the early stage of the protein’s aggregation, most likely by altering the fibrillation
pathway resulting in the formation of unstable fibrillar structures, as observed by TEM (Figure S5B).
The formation of amyloid fibrils can be prevented in a
number of ways: by stabilizing the native structure of the precursor protein or peptide, by inhibiting or altering oligomerization during the early stage of fibrillation and by modulating
or suppressing fibril elongation. Identifying distinct inhibitors
for each of these cases can be a difficult process. The TPETPP fluorescence profiles of RCM α-LA in the presence of
arginine and lysine suggest that both positively charged amino
acids stabilised monomeric RCM α-LA, preventing it from
further aggregation. Ponceau S, a diazo compound, modulated
the prefibrillar RCM α-LA form leading to the formation of
unstable fibrillar species, thereby altering the normal RCM αLA fibrillation pathway as indicated by the extended lagphase. Quinacrine appears to attenuate the rate of RCM α-LA
amyloid formation, producing shorter fibrillar structures.
Thus, by monitoring the TPE-TPP fluorescence associated
with fibril formation, we are able to draw conclusions on the
possible inhibitory mechanism of different fibril inhibitors.
Fluorescence polarization for monitoring the oligomeric
pathway during protein assembly. In addition to measuring
the change in fluorescence intensity during amyloid fibril formation, we recorded the change in fluorescence polarization
(FP) of TPE-TPP. FP reflects the mobility of the emitting species such that when the fluorescent molecule binds to a small
target it freely rotates and has small FP values. However,
when the fluorescent molecule binds to a large molecule, its
rotation/mobility slows and its FP value increases. The alteration in the FP value is therefore proportional to the relative
mass of the object to which it binds 1,47-49. The change in FP of
TPE-TPP during the fibrillation of RCM α-LA, RCM κ-casein
and insulin was therefore measured to examine whether it
could be used to monitor amyloid fibril formation by these
proteins.

A.
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Figure 6. Protein fibril formation monitored by FP. Time-dependent change in FP (∆mP) of TPE-TPP (20 µM) during amyloid fibril formation of (A)
125 µM RCM α-LA, (B) 50 µM RCM κ-casein and (C) 200 µM insulin.

RCM α-LA (monomeric mass 14.7 kDa) follows classical
nucleation-dependent polymerization as apparent from its
sigmoidal kinetic fluorescence curve 30. Starting from monomers, soluble oligomers with increasing mass were formed
after 2 h of incubation, as reflected by the steep increase of the
FP. Afterwards, rigid insoluble fibrils were formed with FP
reaching a maximum value and staying constant over the next
8 h (Figure 6A). On the other hand, RCM κ-casein (monomeric mass ~19 kDa) forms amyloid fibrils via a different mechanism with the absence of a significant lag phase. In solution at
25°C, RCM κ-casein occurs as a spherical particle with a
weight-average molecular mass of ~1180 kDa 50. Consistent
with the difference in molecular mass, the FP of RCM κcasein prior to incubation was higher than that of RCM α-LA
(Figure 6B). At 37 °C and neutral pH, RCM κ-casein reassembles into fibrillar structures 50-52. Amyloid fibril formation by
RCM κ-casein involves the dissociation of its spherical, oligomeric form into a monomeric amyloidogenic precursor,
which then undergoes rapid aggregation to form a nucleus
from which rigid, rod-like amyloid fibrils develop 51,52. Bovine
insulin (monomeric mass 5.8 kDa) forms amyloid fibrils at
acidic pH (pH 2.0) and elevated temperature (60 °C). Insulin
exists as a dimer at acidic pH, which rapidly dissociates to
monomer at higher temperature followed by a conformational
change. The partially unfolded monomers associate with each
other to form oligomeric intermediates including dimers, tetramers and hexamers 53. Hexamers have been reported to be a
critical prefibrillar intermediate in the formation of mature
amyloid fibrils 54. The progression from monomer to dimer,
tetramer, hexamer and then to insulin amyloid fibril is observed by the step-wise increase, each of around similar magnitude in the FP of TPE-TPP (Figure 6C). Thus, TPE-TPPbased FP measurements can map the oligomeric assemblies,
whilst monitoring the fibrillar assembly, of a variety of amyloid fibril-forming protein in situ. Moreover, because FP is
less dependent on the dye concentration, its signal remained
constant after reaching the plateau, whereas a decrease in fluorescence intensity is often observed after the formation of insoluble fibrils (cf Figure 2).
Mechanism of TPE-TPP binding to amyloid fibrils. TPETPP is non-fluorescent in buffer solution owing to the aggregation-induced emission property of its TPE core as the fluorophore. Once bound to a macromolecule such as a protein, the
intramolecular motions of the peripheral phenyl rings of TPE
are restricted, and the dye becomes emissive 23. In contrast to
ThT, TPE-TPP does not have any electron donating or accept-

ing groups conjugated to its fluorogenic unit (Figure 1A).
Therefore, it is unlikely to undergo the twisted intramolecular
charge transfer mechanism ascribed to ThT fluorescence 55,56.
Immediate TPE-TPP fluorescence was observed following
incubation with all the freshly prepared (non-aggregated) proteins used in this study, i.e. α-LA, HEWL, D76N β2m, RCM
κ-casein, αB-crystallin and α-synuclein. However, no further
enhancement of TPE-TPP fluorescence occurred when the
proteins were induced to form the molten globule state or
amorphous aggregates. In contrast, TPE-TPP exhibited significant fluorescence enhancement when incubated with proteins
as they underwent fibril formation. TPE-TPP is like ThT in
binding preferentially to the cross β-sheet structure that is
characteristic of amyloid fibrils. The exact mechanism of ThT
interaction with amyloid fibrils is a matter of debate. Potentially, TPE-TPP could interact with hydrophobic residues and
emit fluorescence. Molten globule states and amorphous aggregates both have significant exposed hydrophobicity but
they do not have well-defined β-sheet conformations in place
and are much more dynamic and less-structured entities than
the highly structured amyloid fibrils and hence do not provide
significant physical constraint to enhance TPE-TPP fluorescence. Thus, TPE-TPP is a fluorescent dye that selectively
monitors in vitro amyloid fibril formation, but not molten
globule states or amorphous (disordered) protein aggregates.
Following incubation, TPE-TPP exhibited in situ and ex situ
fluorescence enhancement much earlier than ThT during protein fibril formation, suggesting that TPE-TPP can interact
with prefibrillar aggregates but not interfere with aggregate
formation. Furthermore, a significant blue shift in the fluorescence emission spectrum of TPE-TPP occurred in the presence
of prefibrillar, oligomeric species compared to native forms of
the same protein (Figures 3A and S3). The blue shift observed
in the fluorescence emission spectrum when TPE-TPP interacted with prefibrillar protein species also occurs for TPE-TPP
in the most viscous solvent, glycerol, when compared with
less viscous solvents or solvents with greater polarity, and is
accompanied by an increase in fluorescence intensity at the
wavelength emission maximum (Figures S6 and S7). For example, the emission maximum of TPE-TPP is ~470 nm in
ethylene glycol but is shifted to ~430 nm in 25% v/v glycerol
and is enhanced in intensity (Figure S6). Only a small change
in Stokes shift is observed when the glycerol percentage is
increased from 25% to 100% v/v but a large and linear increase in fluorescence intensity occurs (Figures S6 and S7).
Such a viscous and rigid local environment could restrict the

intramolecular motions of the excited species and may enable
the transition of the excited species from a higher energy level
to the ground state, resulting in a blue shift of the fluorescence
spectrum. By extrapolation, potentially these observations
imply that the presence of soluble oligomeric assemblies enhances the local viscosity in the surrounding environment of
the TPE-TPP dye. This is consistent with literature reports that
the formation of early-stage soluble oligomeric assemblies
increases the viscosity of the local environment during protein
assembly 57-61.
A red shift in TPE-TPP emission upon binding to RCM αLA mature fibrils also occurred, which was not observed with
D76N β2m fibrils (Figure 3A and S3), suggesting that TPETPP can also detect morphological variations in amyloid fibrils. When the dye molecules bind to the mature fibrils of
ordered structure, they may have to adjust their conformation,
for example via rearranging the dihedral angle between the
phenyl rings and the central double bond of TPE, to fit into the
binding site. As a result, a red shift in the spectrum would be
observer.
TPE-TPP can thus recognise and bind to various protein
forms with different specificity resulting in spectral changes.
Importantly, by monitoring such changes in the TPE-TPP
emission spectrum, it is feasible to differentiate between nonaggregated, pre- and fibrillar protein forms. Although complementary assays based on TEM or atomic force microscopy
are always useful to characterize protein morphology, the possibilities of using TPE-TPP fluorescence provides a rapid and
convenient way to differentiate proteins adopting different
morphologies.
CONCLUSIONS

In summary, our work demonstrates that TPE-TPP has many
advantages over ThT in its applicability to monitor amyloid
fibril formation. TPE-TPP detects the emergence of prefibrillar aggregates, is more robust in monitoring amyloid fibril
formation at highly acidic pH and/or high temperatures, and it
can be used in the presence of exogenous potential inhibitors,
including in high-throughput screening. It also does not undergo self-quenching when present in excess compared to the
concentration of the fibrils, and retains its fluorescence properties when used with aged amyloid fibrils. Furthermore, TPETPP fluorescence can monitor the oligomeric pathway of a
protein during amyloid fibril formation. Thus, we propose that
in many respects, TPE-TPP is a superior dye for fluorescencebased detection and characterization of amyloid fibril aggregation.
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